Skip to main content
Top
Published in: Endocrine 2/2017

01-08-2017 | Research Letter

Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study

Authors: Nadia Pallotta, Tiziana Filardi, Anna Carnovale, Luciano Nieddu, Paola Mariani, Giuseppina Vincoli, Andrea Lenzi, Susanna Morano

Published in: Endocrine | Issue 2/2017

Login to get access

Excerpt

Nonalcoholic fatty liver disease (NAFLD) includes steatosis and nonalcoholic steatohepatitis (NASH), which can be complicated by cirrhosis and hepatocellular carcinoma [1]. NAFLD affects over 30 % of the general population and is associated with type 2 diabetes mellitus (T2DM), obesity and metabolic syndrome [2, 3]. NAFLD prevalence in T2DM patients is about 70 % using ultrasonography (US) [4]. NAFLD and T2DM share insulin-resistance, which in the liver increases gluconeogenesis and glycogenolysis, resulting in hyperglycemia. The pancreatic beta islet cells adapt to hyperglycemia by increasing insulin secretion. Hyperinsulinemia up-regulates several lipogenic transcription factors, promoting hepatic lipid synthesis [5]. The association between NAFLD and T2DM seems to be the result of a “common soil” [3]. Several studies showed that NAFLD predicts T2DM and vice versa, and that each condition may act as a progression factor for the other [4]. There is evidence of a high risk of NASH and its progression to hepatocellular carcinoma in T2DM patients [6]. Conversely, recent studies showed that NAFLD not only predicts diabetes [7], but also contributes to poor glycemic control and chronic complications [8]. Despite its clear link with T2DM, the association of NAFLD with family history of diabetes has been poorly investigated. A recent cross-sectional study in nondiabetic individuals with NAFLD demonstrated that family history of diabetes increased the risk of NASH and fibrosis [9]. …
Literature
1.
go back to reference G.C. Farrell, D. van Rooyen, L. Gan, S. Chitturi, NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 6, 149–171 (2012)CrossRefPubMedPubMedCentral G.C. Farrell, D. van Rooyen, L. Gan, S. Chitturi, NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 6, 149–171 (2012)CrossRefPubMedPubMedCentral
2.
go back to reference R. Loomba, A.J. Sanyal, The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 686–690 (2013)CrossRefPubMed R. Loomba, A.J. Sanyal, The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 686–690 (2013)CrossRefPubMed
3.
go back to reference K.H. Williams, Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr. Rev. 34, 84–129 (2013)CrossRefPubMed K.H. Williams, Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr. Rev. 34, 84–129 (2013)CrossRefPubMed
4.
go back to reference G. Musso, R. Gambino, M. Cassader, G. Pagano, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 43, 617–649 (2011)CrossRefPubMed G. Musso, R. Gambino, M. Cassader, G. Pagano, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 43, 617–649 (2011)CrossRefPubMed
5.
go back to reference R. Lomonaco, C. Ortiz-Lopez, B. Orsak, A. Webb, J. Hardies, C. Darland, J. Finch, A. Gastaldelli, S. Harrison, F. Tio, K. Cusi, Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55, 1389–1397 (2012)CrossRefPubMed R. Lomonaco, C. Ortiz-Lopez, B. Orsak, A. Webb, J. Hardies, C. Darland, J. Finch, A. Gastaldelli, S. Harrison, F. Tio, K. Cusi, Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55, 1389–1397 (2012)CrossRefPubMed
6.
go back to reference I.R. Willner, B. Waters, S.R. Patil, A. Reuben, J. Morelli, C.A. Riely, Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 96, 2957–2961 (2001)CrossRefPubMed I.R. Willner, B. Waters, S.R. Patil, A. Reuben, J. Morelli, C.A. Riely, Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 96, 2957–2961 (2001)CrossRefPubMed
7.
go back to reference C. Ortiz-Lopez, R. Lomonaco, B. Orsak, J. Finch, Z. Chang, V.G. Kochunov, J. Hardies, K. Cusi, Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 35, 873–878 (2012)CrossRefPubMedPubMedCentral C. Ortiz-Lopez, R. Lomonaco, B. Orsak, J. Finch, Z. Chang, V.G. Kochunov, J. Hardies, K. Cusi, Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 35, 873–878 (2012)CrossRefPubMedPubMedCentral
8.
go back to reference G. Targher, M. Chonchol, I. Pichiri, G. Zoppini, Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?. J. Endocrinol. Invest. 34, 544–555 (2011)PubMed G. Targher, M. Chonchol, I. Pichiri, G. Zoppini, Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?. J. Endocrinol. Invest. 34, 544–555 (2011)PubMed
9.
go back to reference R. Loomba, M. Abraham, A. Unalp, L. Wilson, J. Lavine, E. Doo, N.M. Bass, Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56, 943–951 (2012)CrossRefPubMedPubMedCentral R. Loomba, M. Abraham, A. Unalp, L. Wilson, J. Lavine, E. Doo, N.M. Bass, Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56, 943–951 (2012)CrossRefPubMedPubMedCentral
10.
go back to reference C.R.A. Lesmana et al. Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study. Diabetes Metab. Syndr. Obes. 8, 213–218 (2015)CrossRefPubMedPubMedCentral C.R.A. Lesmana et al. Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study. Diabetes Metab. Syndr. Obes. 8, 213–218 (2015)CrossRefPubMedPubMedCentral
11.
go back to reference S.M. Kramer, A.R. Feinstein, Clinical biostatistics: LIV. The biostatistics of concordance. Clin. Pharmacol. Ther. 29, 111–123 (1981)CrossRefPubMed S.M. Kramer, A.R. Feinstein, Clinical biostatistics: LIV. The biostatistics of concordance. Clin. Pharmacol. Ther. 29, 111–123 (1981)CrossRefPubMed
12.
go back to reference K. Shaye, T. Amir, S. Shlomo, S. Yechezkel, Fasting glucose levels within the high normal range predict cardiovascular outcome. Am. Heart. J. 164(1), 111–116 (2012)CrossRefPubMedPubMedCentral K. Shaye, T. Amir, S. Shlomo, S. Yechezkel, Fasting glucose levels within the high normal range predict cardiovascular outcome. Am. Heart. J. 164(1), 111–116 (2012)CrossRefPubMedPubMedCentral
13.
go back to reference F.C. Hsiao, C.H. Hsieh, C.Z. Wu, C.H. Hsu, J.D. Lin, T.I. Lee, D. Pei, Y.L. Chen, Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women. Eur. J. Intern. Med. 24(5), 425–429 (2013). doi:10.1016/j.ejim.2013.03.013 CrossRefPubMed F.C. Hsiao, C.H. Hsieh, C.Z. Wu, C.H. Hsu, J.D. Lin, T.I. Lee, D. Pei, Y.L. Chen, Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women. Eur. J. Intern. Med. 24(5), 425–429 (2013). doi:10.​1016/​j.​ejim.​2013.​03.​013 CrossRefPubMed
14.
go back to reference P. Di Bonito, E. Sanguigno, C. Forziato, F. Saitta, M.R. Iardino, B. Capaldo, Fasting plasma glucose and clustering of cardiometabolic risk factors in normoglycemic outpatient children and adolescents. Diabetes Care 34(6), 1412–1414 (2011). doi:10.2337/dc10-1783 CrossRefPubMedPubMedCentral P. Di Bonito, E. Sanguigno, C. Forziato, F. Saitta, M.R. Iardino, B. Capaldo, Fasting plasma glucose and clustering of cardiometabolic risk factors in normoglycemic outpatient children and adolescents. Diabetes Care 34(6), 1412–1414 (2011). doi:10.​2337/​dc10-1783 CrossRefPubMedPubMedCentral
15.
go back to reference T.V. Fiorentino, M.A. Marini, F. Andreozzi, F. Arturi, E. Succurro, M. Perticone, A. Sciacqua, M.L. Hribal, F. Perticone, G. Sesti, One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. J. Clin. Endocrinol. Metab. 100(10), 3744–3751 (2015). doi:10.1210/jc.2015-2573 CrossRefPubMed T.V. Fiorentino, M.A. Marini, F. Andreozzi, F. Arturi, E. Succurro, M. Perticone, A. Sciacqua, M.L. Hribal, F. Perticone, G. Sesti, One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. J. Clin. Endocrinol. Metab. 100(10), 3744–3751 (2015). doi:10.​1210/​jc.​2015-2573 CrossRefPubMed
16.
go back to reference G. Sesti, M.L. Hribal, T.V. Fiorentino, A. Sciacqua, F. Perticone, Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. Br. Med. J. Open Diabetes Res. Care 2(1), e000016 (2014). doi:10.1136/bmjdrc-2014-000016 CrossRef G. Sesti, M.L. Hribal, T.V. Fiorentino, A. Sciacqua, F. Perticone, Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. Br. Med. J. Open Diabetes Res. Care 2(1), e000016 (2014). doi:10.​1136/​bmjdrc-2014-000016 CrossRef
17.
go back to reference G. Sesti, T.V. Fiorentino, E. Succurro, M. Perticone, F. Arturi, A. Sciacqua, F. Perticone, Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol. 51(6), 927–932 (2014). doi:10.1007/s00592-013-0539-x CrossRefPubMed G. Sesti, T.V. Fiorentino, E. Succurro, M. Perticone, F. Arturi, A. Sciacqua, F. Perticone, Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol. 51(6), 927–932 (2014). doi:10.​1007/​s00592-013-0539-x CrossRefPubMed
18.
go back to reference C.H. Chiang, C.C. Huang, W.L. Chan, J.W. Chen, H.B. Leu, The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clin. Biochem. 43(18), 1399–1404 (2010). doi:10.1016/j.clinbiochem.2010.09.003 CrossRefPubMed C.H. Chiang, C.C. Huang, W.L. Chan, J.W. Chen, H.B. Leu, The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clin. Biochem. 43(18), 1399–1404 (2010). doi:10.​1016/​j.​clinbiochem.​2010.​09.​003 CrossRefPubMed
20.
go back to reference K. Kato, T. Otsuka, N. Kobayashi, Y. Kon, T. Kawada, Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance. Diabet. Med. 31(1), 76–83 (2014). doi:10.1111/dme.12288 CrossRefPubMed K. Kato, T. Otsuka, N. Kobayashi, Y. Kon, T. Kawada, Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance. Diabet. Med. 31(1), 76–83 (2014). doi:10.​1111/​dme.​12288 CrossRefPubMed
21.
go back to reference R. Takahashi, N. Taguchi, M. Suzuki, X.W. Cheng, Y. Numaguchi, H. Tsukamoto, N. Ikeda, T. Murohara, K. Okumura, Cholesterol and triglyceride concentrations in lipoproteins as related to carotid intima-media thickness. Int. Heart J. 53(1), 29–34 (2012)CrossRefPubMed R. Takahashi, N. Taguchi, M. Suzuki, X.W. Cheng, Y. Numaguchi, H. Tsukamoto, N. Ikeda, T. Murohara, K. Okumura, Cholesterol and triglyceride concentrations in lipoproteins as related to carotid intima-media thickness. Int. Heart J. 53(1), 29–34 (2012)CrossRefPubMed
Metadata
Title
Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study
Authors
Nadia Pallotta
Tiziana Filardi
Anna Carnovale
Luciano Nieddu
Paola Mariani
Giuseppina Vincoli
Andrea Lenzi
Susanna Morano
Publication date
01-08-2017
Publisher
Springer US
Published in
Endocrine / Issue 2/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1008-4

Other articles of this Issue 2/2017

Endocrine 2/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.